On the contrary, a low expression of STK38 was discovered in four cancers: breast invasive carcinoma (BRCA), kidney chromophobe (KICH), colon adenocarcinoma (COAD) and prostate adenocarcinoma (PRAD). Here, STK38 is linked to prostate adenocarcinoma.